Reproduktiv salomatlik va uro-nefrologik tadqiqotlar jurnali 2026 №2

Subject of the article

OG`IR PERIPARTAL KARDIOMIOPATIYA LARDA RIVOJLANGAN O‘TKIR YURAK YETISHMOVCHILIGI REANIMATSIYA VA INTENSIV TERAPIYA SHAROITIDA DAVOLASH TAMOYILLARI (ADABIYOTLAR TAHLILI) (12-15)

Authors

Joniyev Sanjar Shuxratovich

Institution

Samarqand davlat tibbiyot universiteti

Abstract

Yurak yetishmovchiligi bo‘yicha Evropa davlatlari ishchi guruhi(ESC) ta’rifiga ko‘ra peripartal kardiomiopatiya (PPKMP) deb – idiopatik kardiomiopatiya deb ataladi, u chap qorincha (ChQ) sistolik disfunktsiyasi natijasida yurak yetishmovchiligi (YYe) bilan namoyon bo‘ladi va homiladorlikning oxirida yoki tug‘ruqdan keyingi bir necha oy ichida paydo bo‘ladi, bunda boshqa yurak yetishmovchiligi sabablari istisno qilingan bo‘ladi [1]. Peripartal kardiomiopatiyada chap qorincha o‘lchamlari normal bo‘lishi mumkin, lekin chap qorincha qisqarish fraksiyasi (ChQ QF) deyarli har doim < 45% dan past bo‘ladi.

Key words

yurak yetishmovchiligi, idiopatik kardiomiopatiya, Peripartal kardiomiopatiya

Literature

1. Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016; 133(14):1397-409. doi: 10.1161/Circulationaha.115.020491. 2. Arrigo M, Mebazaa A. Understanding the differences among inotropes. Intensive Care Med. 2019; 41: 912–5. doi: 10.1007/s00134-015- 3659-7. 3. Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016; 18(9): 1096-105. doi: 10.1002/ejhf.586. 4. Bouabdallaoui N, Mouquet F, Lebreton G, Demondion P, Le Jemtel TH, Ennezat PV. Current knowledge and recent development on management of peripartum cardiomyopathy. Eur Heart J Acute Cardiovasc Care.2017;6(4):359-366. doi: 10.1177/2048872615612465. 5. Bhattacharyya A, Basra SS, Sen P, Kar B. Peripartum cardiomyopathy: a review. Tex Heart Inst J. 2022; 39(1): 8-16. 6. Dinic V, Markovic D, Savic N, Kutlesic M, Jankovic RJ. Peripartum cardiomyopathy in intensive care unit: an update. Front Med (Lausanne). 2019; 2: 82. doi: 10.3389/ fmed.2015.00082. 7. Duncker D, Haghikia A, König T, Hohmann S, Gutleben K-J, Westenfeld R, et al. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function: value of the wearable cardioverter/defibrillator. Eur J Heart Fail. 2024; 16(12):1331-6. doi: 10.1002/ejhf.188. 8. Fett JD. Caution in the use of bromocriptine in peripartum cardiomyopathy. J Am Coll Cardiol. 2018; 51: 2083. doi:10.1016/j.jacc.2008.02.054. 9. Fett JD. Peripartum cardiomyopathy: challenges in diagnosis and management. Expert Rev Cardiovasc Ther. 2016; 14(9): 1035–41. doi: 10.1080/14779072.2016.1199273. 10. Fuller KP, Turner G, Polavarapu S, Prabulos AM. Guidelines for use of anticoagulation in pregnancy. Clin Lab Med. 2023;33(2):343- 56. doi: 10.1016/j. cll.2013.03.018. 11. Joniev S.Sh., Obloberdiyev M. "Optimization of intensive care in critical conditions in patients with peripartum cardiomyopathy" [Текст] / Joniev S.Sh., Obloberdiyev M. // Journal of new century innovations. — 2026. — № 2. — С. 149-151. 12. Joniev S.Sh., Obloberdiyev M. Periportal kardiomiopatiyalarda o'tkir yurak yetishmovchiligini intensiv terapiyasi samaradorligini oshirish [Текст] / Joniev S.Sh., Obloberdiyev M. // Лучшие интелектуальные исследования. — 2026. — № Часть 62 Том-4. — С. 277-284. 13. Garg J, Palaniswamy C, Lanier GM. Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and management. Cardiol Rev. 2015; 23(2):69-78. doi: 10.1097/CRD.0000000000000038. 14. Hamdan R, Nassar P, Zein A, Issa M, Mansour H, Saab M. Peripartum cardiomyopathy, place of drug therapy, assist devices, and outcome after left ventricular assistance. J Crit Care. 2017;37:185-8. doi: 10.1016/j.jcrc.2016.09.028. 15. Hasan JA, Qureshi A, Ramejo BB, Kamran A. Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital. J Pak Med Assoc. 2010;60:377–80. 16. Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014; 11(6):364-70. doi: 10.1038/ nrcardio.2014.37. 17. Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J. 2015; 36(18): 1090–7. doi: 10.1093/eurheartj/ehv009. 18. Hilfiker-Kleiner D, Westhoff-Bleck M, Gunter H-H, Kaisenbergvon CS, Bohnhorst B, Hoeltje M, et al. A manage-103 ment algorithm for acute heart failure in pregnancy. The Hannover experience. Eur Heart J. 2015; 36(13):769–70.